Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001445815-23-000002
Filing Date
2023-02-08
Accepted
2023-02-08 11:40:03
Documents
1
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 5699
  Complete submission text file 0001445815-23-000002.txt   7425
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Issuer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 47 HAMMOND STREET UNIT 2 WALTHAM MA 02451
Business Address
Soderquist Ola (Reporting) CIK: 0001754429 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-35027 | Film No.: 23597833